Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18910de2653c0a59160eb05041e6ae7c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ed3ad724da61b0c6f121387f321179c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fc39ef1a76afa0c259b03d033fd15b59 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-24 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56972 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5047 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 |
filingDate |
2012-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2020-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4932bfd7bd29dd619b6508ab1f005586 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b2a22c6b0d3f11afed1b1971453a9a2 |
publicationDate |
2020-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-10551380-B2 |
titleOfInvention |
TLR agonist-enhanced in vitro assay of cell mediated immune responsiveness |
abstract |
This disclosure relates generally to the field of immunological-based diagnostic assays including an assay to measure cell-mediated immunoresponsiveness. The present disclosure teaches determination of the state, progression and/or severity of disease conditions based on a subject's cell-mediated immunoresponsiveness. The assay contemplated herein is capable of integration into standard pathology architecture to provide a diagnostic reporting system and to facilitate point of care clinical management. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020271648-A1 |
priorityDate |
2011-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |